Hospital
RSSArticles
-
Servicewomen Experience Barriers to Contraception
A follow-up survey of United States servicewomen and their access to contraceptives during their deployment revealed both good and bad news. Some women reported greater access to contraception, while others experienced barriers to obtaining contraceptives in the weeks leading up to their deployment.
-
Study: Copper IUDs Do Not Appear to Prevent Implantation or Increase HIV Risk
For decades, clinicians and the public assumed that copper intrauterine devices (IUDs) prevented pregnancy by preventing implantation. There also was fear that IUDs could increase a woman’s risk of HIV infection. Results of a new study suggested these assumptions are incorrect.
-
Contraceptive Implants Are an Option for Patients Taking Isotretinoin
When clinicians prescribe the acne medication isotretinoin, they advise reproductive-age women to avoid pregnancy through two different contraceptives and an online iPledge app. Since the drug causes severe birth defects, it is important young women do not become pregnant while taking the drug. Etonogestrel contraceptive implants could be one contraceptive option for women taking isotretinoin, but there are concerns the acne drug would decrease the effectiveness of hormonal contraceptives.
-
Associations and Regulators Recommend Guidelines for Reopening Clinics
The American College of Obstetricians and Gynecologists and the Infectious Diseases Society of America offered guidelines for how physician offices, clinics, and other facilities can reopen to in-person, nonessential services in the next phase of the pandemic.
-
Abortion Access Problems Arise During COVID-19 Pandemic
Some states used the COVID-19 pandemic to stop abortion clinics from operating, saying abortions were nonessential medical services. Lawsuits helped reopen some sites, but abortion access was limited.
-
Research Organizations Face Challenges New and Old
As current studies resume and new studies are approved, IRBs and researchers should keep basic safety and regulatory practices in mind, according to experts on the front lines of human research protection and clinical trials.
-
Q&A Part 3: IRBs Learn Positive and Instructional Lessons from Pandemic
IRB experts share the ways in which the pandemic has spurred innovation in their institutions.
-
Q&A Part 2: How IRB Leaders Helped Staff, Board Members Cope with Uncertainty
Communication, stress, and anxiety were top concerns for IRB leaders and staff during the early days of the COVID-19 pandemic.
-
Q&A Part 1: IRBs Face Their Toughest Challenges with COVID-19
IRB leaders describe the challenges staff faced during the transition to remote working.
-
IRB Pandemic Impact Report
In this question and answer special report, a dozen IRB administrators, directors, chairs, and other leaders from across the United States were asked about their facilities’ experiences during the COVID-19 pandemic’s early weeks.